Literature DB >> 22391592

Letter to the Editor: Regarding: Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD (2011) Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supp Care Cancer 19;1969-1974.

Kenneth V Rolston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391592     DOI: 10.1007/s00520-012-1419-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

1.  Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.

Authors:  Madonna J Matar; Jeffrey Tarrand; Issam Raad; Kenneth V I Rolston
Journal:  Am J Infect Control       Date:  2006-10       Impact factor: 2.918

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

3.  High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.

Authors:  Ravina Kullar; Susan L Davis; Donald P Levine; Jing J Zhao; Christopher W Crank; John Segreti; George Sakoulas; Sara E Cosgrove; Michael J Rybak
Journal:  Pharmacotherapy       Date:  2011-06       Impact factor: 4.705

4.  Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Authors:  Shawna Kraft; Emily Mackler; Peter Schlickman; Kathy Welch; Daryl D DePestel
Journal:  Support Care Cancer       Date:  2010-11-26       Impact factor: 3.603

5.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

6.  Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.

Authors:  Kenneth H Rand; Herbert Houck
Journal:  J Antimicrob Chemother       Date:  2004-02-12       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.